HomeCompareBAX vs COP

BAX vs COP: Dividend Comparison 2026

BAX yields 2.28% · COP yields 2.44%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 COP wins by $86.67M in total portfolio value
10 years
BAX
BAX
● Live price
2.28%
Share price
$15.80
Annual div
$0.36
5Y div CAGR
-27%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.6K
Annual income
$10.26
Full BAX calculator →
COP
COP
● Live price
2.44%
Share price
$132.89
Annual div
$3.24
5Y div CAGR
96.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$86.69M
Annual income
$79,275,909.08
Full COP calculator →

Portfolio growth — BAX vs COP

📍 COP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBAXCOP
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BAX + COP cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BAX pays
COP pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BAX
Annual income on $10K today (after 15% tax)
$193.67/yr
After 10yr DRIP, annual income (after tax)
$8.72/yr
COP
Annual income on $10K today (after 15% tax)
$207.24/yr
After 10yr DRIP, annual income (after tax)
$67,384,522.72/yr
At 15% tax rate, COP beats the other by $67,384,514.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BAX + COP for your $10,000?

BAX: 50%COP: 50%
100% COP50/50100% BAX
Portfolio after 10yr
$43.36M
Annual income
$39,637,959.67/yr
Blended yield
91.43%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on COP right now

BAX
Analyst Ratings
15
Buy
20
Hold
1
Sell
Consensus: Hold
Price Target
$19.75
+25.0% upside vs current
Range: $15.00 — $25.00
Altman Z
2.1
Piotroski
5/9
COP
Analyst Ratings
1
Strong
37
Buy
11
Hold
3
Sell
Consensus: Buy
Price Target
$116.79
-12.1% upside vs current
Range: $98.00 — $133.00
Altman Z
3.4
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BAX buys
0
COP buys
0
No recent congressional trades found for BAX or COP in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBAXCOP
Forward yield2.28%2.44%
Annual dividend / share$0.36$3.24
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-27%96.6%
Portfolio after 10y$20.6K$86.69M
Annual income after 10y$10.26$79,275,909.08
Total dividends collected$602.00$86.10M
Payment frequencyquarterlyquarterly
SectorHealthcareEnergy
Analyst consensusHoldBuy
Analyst price target$19.75$116.79

Year-by-year: BAX vs COP ($10,000, DRIP)

YearBAX PortfolioBAX Income/yrCOP PortfolioCOP Income/yrGap
1← crossover$10,866$166.33$11,179$479.33$313.00COP
2$11,750$123.31$12,946$984.58$1.2KCOP
3$12,664$90.97$15,948$2,095.01$3.3KCOP
4$13,617$66.89$21,806$4,741.70$8.2KCOP
5$14,619$49.07$35,245$11,912.61$20.6KCOP
6$15,679$35.94$73,090$35,377.72$57.4KCOP
7$16,802$26.30$213,006$134,800.18$196.2KCOP
8$17,998$19.23$949,732$721,815.83$931.7KCOP
9$19,272$14.05$6,929,588$5,913,373.93$6.91MCOP
10$20,631$10.26$86,690,568$79,275,909.08$86.67MCOP

BAX vs COP: Complete Analysis 2026

BAXHealthcare

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Full BAX Calculator →

COPEnergy

ConocoPhillips explores for, produces, transports, and markets crude oil, bitumen, natural gas, liquefied natural gas (LNG), and natural gas liquids worldwide. It primarily engages in the conventional and tight oil reservoirs, shale gas, heavy oil, LNG, oil sands, and other production operations. The company's portfolio includes unconventional plays in North America; conventional assets in North America, Europe, Asia, and Australia; various LNG developments; oil sands assets in Canada; and an inventory of conventional and unconventional exploration prospects. ConocoPhillips was founded in 1917 and is headquartered in Houston, Texas.

Full COP Calculator →
📬

Get this BAX vs COP comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BAX vs SCHDBAX vs JEPIBAX vs OBAX vs KOBAX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.